首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardio-oncology

缩写:

ISSN:N/A

e-ISSN:2057-3804

IF/分区:3.2/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引484
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Muhammad Umar,Aizaz Ali,Avirup Guha et al. Muhammad Umar et al.
Purpose: Anthracyclines are widely used anticancer agents but are limited by dose-dependent cardiotoxicity. Ivabradine selectively reduces heart rate without negative inotropy and may offer cardio protection in cancer pat...
Alexis Behne Sharma,Elicia Wang,Sruthi Selvakumar et al. Alexis Behne Sharma et al.
Background: Myelofibrosis (MF) is a subgroup of Philadelphia chromosome-negative myeloproliferative neoplasms that are associated with an increased risk of cardiovascular disease, including pulmonary hypertension. Here we...
Lama Alfehaid,Nada Alsuhebany,Khalid Alamer et al. Lama Alfehaid et al.
Background: The HFA-ICOS baseline cardiovascular risk stratification framework is widely recommended to guide surveillance in patients receiving potentially cardiotoxic cancer therapies, yet real-world evidence supporting...
Kristina Charaya,Irina Sokolova,Elnara Abdullaeva et al. Kristina Charaya et al.
Background: Nonbacterial thrombotic endocarditis (NBTE) is an uncommon but important cause of systemic arterial embolism, most often occurring in advanced malignancy. Diagnosis is frequently difficult because vegetations ...
Ana Cláudia Aparecida Santos Nussbaum,Marcelo Antonini,André Mattar et al. Ana Cláudia Aparecida Santos Nussbaum et al.
Monoclonal antibody-based therapies have substantially improved outcomes in breast cancer, particularly through HER2-directed treatment strategies, but have also introduced important cardiovascular toxicities that require careful recognitio...
Sarah Jung,Rebecca Steinberg,Angel Ji et al. Sarah Jung et al.
Background: Nearly 20% of patients with neuroendocrine tumors (NET) develop carcinoid syndrome (CS), and 20-25% of those with CS develop carcinoid heart disease (CHD). Contemporary risk factors for CHD and prognostic vari...
Benji van Berlo,Pierangela Esposito,Alessandra Greco et al. Benji van Berlo et al.
Background: The higher incidence of cancer in patients with cardiovascular disease (CVD) has historically been explained by shared risk factors. Recent studies suggest, however, a causal relationship. Nevertheless, the me...
Alfred Chung Pui So,John Conibear,Adam Januszweski et al. Alfred Chung Pui So et al.
Background: Treatment options for malignant loculated pericardial effusions are limited and effusions often reaccumulate following surgical management. For posterior effusions, access percutaneously is challenging, hence ...
Joshua Ayoson,Nadine Schneider,Nina Müller et al. Joshua Ayoson et al.
Background/objective: Cardiovascular disease (CVD) is a major and potentially life-threatening late effect in cancer survivors, in some populations surpassing the risk of cancer recurrence as a leading cause of mortality....